What is Immunovant, Inc.'s PP&E (net)?

Immunovant, Inc. (IMVT) reported PP&E (net) of $443K in Q1 2026.

How has Immunovant, Inc.'s PP&E (net) changed year-over-year?

Immunovant, Inc.'s PP&E (net) decreased by 47.5% year-over-year, from $844K to $443K.

What is the long-term trend for Immunovant, Inc.'s PP&E (net)?

Over 5 years (2021 to 2026), Immunovant, Inc.'s PP&E (net) has grown at a 17.1% compound annual growth rate (CAGR), from $201K to $443K.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Immunovant, Inc. IMVT PP&E (Net)

PP&E (Net) at other companies

Johnson & JohnsonJNJ

$23.27B+11.5%

ImmunityBio, Inc.IBRX

$112.79M-16.6%

Summit TherapeuticsSMMT

$1.66M+155%

Roivant SciencesROIV

$11.99M-0.6%

Apogee Therapeutics, Inc.APGE

——

Protagonist TherapeuticsPTGX

——

Other financials

Income statement

See full

Net income-$147.9M-38.9%

EPS (diluted)-$0.73-15.9%

Balance sheet

See full

Cash & equivalents$902.1M+26.4%

Total debt$72.0K-26.5%

Total equity$852.6M+20.5%

Total assets$957.0M+23.3%

Cash flow

See full

Operating cash flow-$95.1M+14.1%

CapEx$8.0K-96.0%

Free cash flow-$95.1M+14.2%

Valuation

See full

Market cap$7.26B+74.2%

Enterprise value$6.35B+89.7%

Returns & leverage

See full

Return on equity-64.8%+2.5pp

Debt / equity0×0.0×

Current ratio9.1×-2.1×

Where this comes from

Reported directly by Immunovant, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Immunovant, Inc.’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immunovant, Inc.'s pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Immunovant, Inc.'s PP&E (net)?: Immunovant, Inc. (IMVT) reported PP&E (net) of $443K in Q1 2026.
How has Immunovant, Inc.'s PP&E (net) changed year-over-year?: Immunovant, Inc.'s PP&E (net) decreased by 47.5% year-over-year, from $844K to $443K.
What is the long-term trend for Immunovant, Inc.'s PP&E (net)?: Over 5 years (2021 to 2026), Immunovant, Inc.'s PP&E (net) has grown at a 17.1% compound annual growth rate (CAGR), from $201K to $443K.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.